IgG4/IgG RNA ratio does not accurately discriminate IgG4-related disease from pancreatobiliary cancer.
Ontology highlight
ABSTRACT: Highlights•IgG4-related disease and malignancy of bile ducts/pancreas can be indistinguishable.•Blood IgG4/IgG RNA ratio was prospectively tested as an IgG4-RD marker when malignancy was suspected.•IgG4/IgG RNA ratio >5% did not accurately discriminate IgG4-RD from pancreatobiliary cancer.
SUBMITTER: de Vries E
PROVIDER: S-EPMC7332528 | biostudies-literature | 2020 Aug
REPOSITORIES: biostudies-literature
ACCESS DATA